Cancer Genetics, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (25)

Latest Posts

About This Stock More About This Stock
Week In Review: Innovent's Hong Kong IPO: Raising $422 Million At $2 Billion Valuation
Article By: ChinaBio® Today
Saturday, October 20, 2018 4:16 PM EDT
Innovent Biologics of Suzhou plans to raise $422 million in its Hong Kong IPO at a $2 billion valuation, according to multiple media reports. The company, formed in 2011, struck a major $1 billion collaboration with Lilly in 2015.
In this article: LLY, APDN, CGIX, HCM
Week In Review: JHL Biotech Signs $257 Million Biosimilar Deal With Sanofi
Article By: ChinaBio® Today
Saturday, December 10, 2016 12:44 PM EDT
JHL Biotech, a Taiwan-China biologics company, signed a $257 million partnership agreement that gives Sanofi rights to market a JHL clinical-stage rituximab biosimilar, initially for China.
In this article: AZN, NVS, SNY, CGIX, BGNE
Cancer Genetics Announces $5 Million Registered Direct Offering
Article By: NASDAQ GlobeNewswire
Friday, May 20, 2016 6:40 PM EDT
Concurrently in a private placement, for each share of common stock purchased by an investor, such investor will receive from the Company an unregistered warrant to purchase one-half of a share of common stock.
In this article: CGIX
4 Hot Stocks To Keep An Eye Out For In Medical Services
Article By: Zacks Investment Research
Tuesday, March 22, 2016 1:08 PM EDT
Uncertainty is not new to the world of investing. A regular investor knows that nothing pays off better than adequate, up-to-date knowledge of the current market and one’s current portfolio.
In this article: ICLR, PRXL, CGIX, PRAH
Heavy Insider Buying Could Signal Big Rallies For These 3 Stocks
Article By: Bret Jensen
Tuesday, April 14, 2015 9:52 PM EDT
Here are a few small biotech stocks that have garnered considerable interest recently from notable investors as of late.
In this article: KERX, CGIX, SNTA

Latest Tweets for $CGIX

No tweets yet!